» Go to news main
Molly Appeal paves the way to precision cancer treatment
A group of Dalhousie Medical School researchers is spearheading a new initiative to develop personalized cancer treatments, with support from Dalhousie Medical Research Foundation’s 2017-18 Molly Appeal.
“Every person’s cancer is as unique as their fingerprints,” says Dr. Paola Marignani, an internationally known cancer researcher and professor in Dalhousie’s Department of Biochemistry & Molecular Biology who’s leading this year’s Molly Appeal research initiative.
Read more on Dal News.
- Dr. Shashi Gujar receives Canadian Cancer Society Emerging Scholar Award
- Dal Health researcher part of largest vaccine safety study in Canadian history
- Doctor for a Day at DMNB workshops go virtual for New Brunswick March break
- One year later: Faculty of Medicine dean reflects on the COVID‑19 upheaval
- Med students create video series to dispel COVID myths
- Government of Canada invests in research through CIHR Project Grant program
- #ChooseToChallenge: The First Female Medical Graduate from Dalhousie
- Dr. Gaynor Watson‑Creed named to federal Task Force on Women in the Economy